Concord Biotech informs about earnings call

31 Jan 2025 Evaluate
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended from time to time, read with Para A of Schedule III thereto, Concord Biotech has informed that the Company has arranged Earnings Call with Investor/Analyst (Participants) to discuss the Unaudited Standalone and Consolidated Financial Results of the Company for the third quarter and nine months ended 31st December, 2024, scheduled on Friday, 14th February, 2025 at 04:00 pm IST. The Earnings Call invite is enclosed.

The above information is a part of company’s filings submitted to BSE.

Concord Biotech Share Price

1495.20 -94.85 (-5.97%)
28-Feb-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1593.90
Dr. Reddys Lab 1117.65
Cipla 1410.95
Lupin 1906.20
Zydus Lifesciences 876.20
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...